Biome Australia Limited
Research Biome Australia Limited (BIO.AX) on Bullrun: market cap AUD 93.72M, P/E 20.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIO.AX
- ExchangeAU
- CountryAustralia
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyAUD
- Market capAUD 93.72M
- P/E20.3
- Financial periodFY2025
Valuation Snapshot
latest market cap is AUD 93.72M; P/E is 20.3.
Peer valuation comparison
Latest P/E is 20.25x versus a Consumer Defensive sector median of 17.14x (18.2% above).
Latest P/E is 20.25x versus a Australia median of 15.06x (34.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a |
| FY2024 | AUD 13.01M | -AUD 1.67M | -AUD 185.41K | 60.8% | -0.01 | AUD 2.87M | AUD 1.30M | AUD 2.90M |
| FY2023 | AUD 7.24M | -AUD 3.08M | -AUD 3.90M | 59.1% | -0.02 | AUD 2.26M | AUD 1.15M | AUD 3.59M |
| FY2022 | AUD 4.11M | -AUD 4.54M | -AUD 3.55M | 57.8% | -0.03 | AUD 5.49M | AUD 467.05K | AUD 6.53M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | AUD 93.72M | 20.3 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Biome Australia Limited
Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health practitioners, and health professionals.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Biome Australia Limited's market cap?
Biome Australia Limited's market capitalization is AUD 93.72M.
What is Biome Australia Limited's P/E ratio?
Biome Australia Limited's price-to-earnings (P/E) ratio is 20.3.
What does Biome Australia Limited do?
Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.